References in this report (the "Quarterly Report") to "we," "us" or the
"Company" refer to Atlantic Coastal Acquisition Corp. References to our
"management" or our "management team" refer to our officers and directors, and
references to the "Sponsor" refer to Atlantic Coastal Acquisition Management
LLC. The following discussion and analysis of our financial condition and
results of operations should be read in conjunction with our financial
statements and the related notes thereto contained elsewhere in this Quarterly
Report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act
that are not historical facts and involve risks and uncertainties that could
cause actual results to differ materially from those expected and projected. All
statements, other than statements of historical fact included in this Form 10-Q
including, without limitation, statements in this "Management's Discussion and
Analysis of Financial Condition and Results of Operations" regarding the
completion of the Proposed Business Combination (as defined below), the
Company's financial position, business strategy and the plans and objectives of
management for future operations, are forward-looking statements. Words such as
"expect," "believe," "anticipate," "intend," "estimate," "seek" and variations
and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future
performance, but reflect management's current beliefs, based on information
currently available. A number of factors could cause actual events, performance
or results to differ materially from the events, performance and results
discussed in the forward-looking statements, including that the conditions of
the Proposed Business Combination are not satisfied. For information identifying
important factors that could cause actual results to differ materially from
those anticipated in the forward-looking statements, please refer to the Risk
Factors section of the Company's Annual Report on Form 10-K filed with the U.S.
Securities and Exchange Commission (the "SEC") and those factors described under
the heading "Item 1A. Risk Factors" of this Quarterly Report. The Company's
securities filings can be accessed on the EDGAR section of the SEC's website at
www.sec.gov. Except as expressly required by applicable securities law, the
Company disclaims any intention or obligation to update or revise any
forward-looking statements whether as a result of new information, future events
or otherwise.
Overview
We are a blank check company incorporated in Delaware on December 7, 2020 for
the purpose of effecting a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination with one or more
businesses. We intend to effectuate our Business Combination using cash from the
proceeds of the Initial Public Offering and the sale of the Private Placement
Warrants, our capital stock, debt or a combination of cash, stock and debt.
We expect to continue to incur significant costs in the pursuit of our
acquisition plans. We cannot assure you that our plans to complete a Business
Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date.
Our only activities from December 7, 2020 (inception) through March 31, 2022
were organizational activities, those necessary to consummate the Initial Public
Offering, described below, and identifying a target company for a Business
Combination. We do not expect to generate any operating revenues until after the
completion of our Business Combination. We generate non-operating income in the
form of interest dividends on marketable securities held in the Trust Account.
We incur expenses as a result of being a public company (for legal, financial
reporting, accounting and auditing compliance), as well as for due diligence and
transaction expenses.
For the three months ended March 31, 2022, we had net income of $8,883,557,
which consists of a change in fair value of warrant liabilities of $11,955,871
and interest earned on marketable securities held in Trust Account of $138,352,
offset by operational costs of $2,881,785 and unrealized loss on marketable
securities held in Trust Account of $328,881.
23
Table of Contents
For the three months ended March 31, 2021, we had a net loss of $604,983, which
consists of operational costs of $755,768, offset by a change in fair value of
warrant liabilities of $100,000, and interest earned on marketable securities
held in Trust Account of $413.
Proposed Business Combination and Termination
On November 30, 2021, we entered into a Business Combination Agreement (the
"Business Combination Agreement") with Alpha Merger Sub 1, Inc., a Delaware
corporation and our direct wholly-owned subsidiary ("Merger Sub"), and
Essentium, Inc., a Delaware corporation ("Essentium"). On February 9, 2022, we,
Merger Sub, and Essentium entered into a Termination and Fee Agreement (the
"Termination Agreement"). Pursuant to the Termination Agreement, the parties
agreed to mutually terminate the Business Combination Agreement, subject to the
conditions set forth in the Termination Agreement.
The Termination Agreement provides that we will be entitled to receive cash
payments or a warrant to acquire Essentium shares (the "Termination Proceeds"),
subject to the occurrence of certain events, as follows: (i) the lesser of (a)
an amount in cash equal to five percent (5)% of the aggregate gross proceeds to
Essentium of all Financing Transactions (as defined in the Termination
Agreement) consummated on or prior to March 8, 2023 and (b) $7,500,000, (ii) if
Essentium consummates a Sale of the Company (as defined in the Termination
Agreement) on or before March 8, 2023, the greater of (a) $2,000,000 and (b) an
amount in cash equal to five percent (5)% of the net proceeds received by
Essentium upon the consummation of such Sale of the Company, (iii) if Essentium
has not consummated a Sale of the Company on or prior to March 8, 2023, a
warrant to acquire a number of Essentium shares in an amount equal to five
percent (5)% of the Fully Diluted Shares Outstanding (as defined in the Business
Combination Agreement) as of February 9, 2022, as adjusted to take into account
any stock split, stock dividend or similar event effected with respect to
Essentium's shares on or after the February 9, 2022 and on or prior to the date
of the warrant, with an exercise price reflective of an implied equity value for
Essentium of $500,000,000 as of the date of the warrant and (iv) if Essentium
has not consummated a Sale of the Company on or prior to March 8, 2023, and we
determine to redeem our public shares and liquidate or dissolve on or after
March 8, 2023 (and do not withdraw such determination), an amount equal to
$2,000,000.
The Termination Agreement contains mutual releases by all parties thereto, for
all claims known and unknown, relating and arising out of, or relating to, among
other things, the Business Combination Agreement, or the transactions
contemplated by the Business Combination Agreement, subject to certain
exceptions with respect to claims for indemnity or contribution.
The foregoing description of the Termination Agreement is subject to and
qualified in its entirety by reference to the full text of the Termination
Agreement, a copy of which is included as Exhibit 10.1 in this Form 10-Q and
incorporated herein by reference. Certain of the Termination Proceeds, when
received by us, would be allocable to the payment for fees and expenses of our
advisors.
We intend to continue our search for an initial Business Combination.
Liquidity and Capital Resources
On March 8, 2021, we consummated our Initial Public Offering of 30,000,000 Units
at $10.00 per Unit, generating gross proceeds of $300,000,000. Simultaneously
with the closing of our Initial Public Offering, we consummated the sale of
5,466,667 Private Placement Warrants at a price of $1.50 per Private Placement
Warrant in a private placement to the Sponsor, generating gross proceeds of
$8,200,000. On April 23, 2021, the underwriters purchased an additional
4,500,000 units pursuant to their exercise of the over-allotment option in full,
generating gross proceeds of $45,000,000. In connection with the underwriters'
exercise of their over-allotment option, the Sponsor purchased an additional
600,000 Private Placement Warrants, generating additional gross proceeds of
$900,000.
For the three months ended March 31, 2022, cash used in operating activities was
$162,069. Net income of $8,883,557 was affected by change in fair value of
warrant liabilities of $11,955,871, interest earned on marketable securities
held in Trust Account of $138,352 and unrealized loss on marketable securities
held in the Trust Account of $328,881. Net changes in operating assets and
liabilities provided $2,719,717 of cash for operating activities.
For the three months ended March 31, 2021, cash used in operating activities was
$1,236,313. Net loss of $604,983 was affected by dividends earned on marketable
securities held in Trust Account of $413, a change in fair value of the warrant
liabilities of $100,000, and transaction costs associated with the Initial
Public Offering of $428,394. Net changes in operating assets and liabilities
used $959,310 of cash for operating activities.
24
Table of Contents
As of March 31, 2022, we had marketable securities held in the Trust Account of
$344,833,170 (including approximately $191,000 of interest income and unrealized
loss, net) consisting of mutual funds which invest primarily in U.S. Treasury
Bills with a maturity of 185 days or less. Interest income on the balance in the
Trust Account may be used by us to pay taxes. Through March 31, 2022, we have
not withdrawn any interest earned from the Trust Account.
We intend to use substantially all of the funds held in the Trust Account,
including any amounts representing interest earned on the Trust Account (less
income taxes payable), to complete our Business Combination. To the extent that
our capital stock or debt is used, in whole or in part, as consideration to
complete our Business Combination, the remaining proceeds held in the Trust
Account will be used as working capital to finance the operations of the target
business or businesses, make other acquisitions and pursue our growth
strategies.
As of March 31, 2022, we had cash of $27,539. We intend to use the funds held
outside the Trust Account primarily to identify and evaluate target businesses,
perform business due diligence on prospective target businesses, travel to and
from the offices, plants or similar locations of prospective target businesses
or their representatives or owners, review corporate documents and material
agreements of prospective target businesses, and structure, negotiate and
complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in
connection with a Business Combination, our Sponsor, or certain of our officers
and directors or their affiliates may, but are not obligated to, loan us funds
as may be required. If we complete a Business Combination, we would repay such
loaned amounts. In the event that a Business Combination does not close, we may
use a portion of the working capital held outside the Trust Account to repay
such loaned amounts but no proceeds from our Trust Account would be used for
such repayment. Up to $1,500,000 of such Working Capital Loans may be
convertible into warrants of the post-Business Combination entity at a price of
$1.50 per warrant. The warrants would be identical to the Private Placement
Warrants.
Through the target identification process, we will be using these funds for
paying existing accounts payable, identifying and evaluating prospective initial
Business Combination candidates, performing due diligence on prospective target
businesses, paying for travel expenditures, selecting the target business to
merge with or acquire, and structuring, negotiating and consummating the
Business Combination.
On August 9, 2021, our Sponsor signed a Commitment Letter to provide up to
$1,315,000 in working capital loans if required. On November 11, 2021, our
Sponsor amended the August 9, 2021, Commitment Letter to provide $1,055,000 in
working capital loans in addition to the previously provided $1,315,000.
On December 14, 2021, our Sponsor paid for certain operating costs on behalf of
the Company amounting to $62,500. The advances were non-interest bearing and due
on demand.
On April 18, 2022, pursuant to a promissory note, we were advanced $250,000 from
Shahraab Ahmad, Chief Executive Officer of the Company. This loan is
non-interest bearing and payable upon the earlier of (i) completion of an
initial Business Combination or (ii) liquidation if there is no initial Business
Combination.
Going Concern
As of March 31, 2022, we had cash of $27,539 not held in the Trust Account and
available for working capital purposes and total current liabilities of
$8,553,417.
We will need to raise additional capital through loans or additional investments
from our Sponsor, stockholders, officers, directors, or third parties. Our
officers, directors and Sponsor may, but are not obligated to, loan us funds,
from time to time or at any time, in whatever amount they deem reasonable in
their sole discretion, to meet our working capital needs. Accordingly, we may
not be able to obtain additional financing. If we are unable to raise additional
capital, we may be required to take additional measures to conserve liquidity,
which could include, but not necessarily be limited to, curtailing operations,
suspending the pursuit of a potential transaction, and reducing overhead
expenses. We cannot provide any assurance that new financing will be available
to us on commercially acceptable terms, if at all. These conditions raise
substantial doubt about our ability to continue as a going concern through March
8, 2023, the date that we will be required to cease all operations, except for
the purpose of winding up, if a Business Combination is not consummated. These
financial statements do not include any adjustments relating to the recovery of
the recorded assets or the classification of the liabilities that might be
necessary should we be unable to continue as a going concern.
25
Table of Contents
In connection with the Company's assessment of going concern considerations in
accordance with Accounting Standards Codification ("ASC") Topic 205-40
Presentation of Financial Statements - Going Concern, the Company has until
March 8, 2023, to consummate a Business Combination. If a Business Combination
is not consummated by this date and an extension not requested by the Sponsor,
there will be a mandatory liquidation and subsequent dissolution of the Company.
Although the Company intends to consummate a Business Combination on or before
March 8, 2023, it is uncertain that the Company will be able to consummate a
Business Combination by this time. Management has determined that the liquidity
condition, coupled with the mandatory liquidation, should a Business Combination
not occur, and an extension is not requested by the Sponsor, and potential
subsequent dissolution raises substantial doubt about the Company's ability to
continue as a going concern. The Company's plan is to complete a business
combination or obtain an extension on or prior to March 8, 2023, however it is
uncertain that the Company will be able to consummate a Business Combination or
obtain an extension by this time. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate
after March 8, 2023.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance sheet arrangements as of March 31, 2022. We do not participate in
transactions that create relationships with unconsolidated entities or financial
partnerships, often referred to as variable interest entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements.
We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of
other entities, or purchased any non-financial assets.
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating lease
obligations or long-term liabilities, other than an agreement to pay Atlantic
Coastal Acquisition Management LLC a monthly fee of $10,000 for office space,
utilities and secretarial and administrative support. We began incurring these
fees on March 1, 2021 and will continue to incur these fees monthly until the
earlier of the completion of the Business Combination and our liquidation. For
the three months ended March 31, 2022 and 2021, the Company incurred $10,000 and
$30,000 in fees for these services, of which such amount is included in accrued
expenses in the accompanying March 31, 2022, condensed balance sheet.
The underwriters are entitled to a deferred fee of $0.35 per Unit, or
$12,075,000 in the aggregate. The deferred fee will become payable to the
underwriters from the amounts held in the Trust Account solely in the event that
the Company completes a Business Combination, subject to the terms of the
underwriting agreement.
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities, disclosure of contingent assets and
liabilities at the date of the financial statements, and income and expenses
during the periods reported. Actual results could materially differ from those
estimates. We have identified the following critical accounting policies:
Warrant Liabilities
We account for the Warrants in accordance with the guidance contained in ASC
815-40-15-7D and 7F under which the Warrants do not meet the criteria for equity
treatment and must be recorded as liabilities. Accordingly, we classify the
Warrants as liabilities at their fair value and adjust the Warrants to fair
value at each reporting period. This liability is subject to re-measurement at
each balance sheet date until exercised, and any change in fair value is
recognized in our statements of operations. The Private Warrants and the Public
Warrants for periods where no observable traded price was available are valued
using a lattice Model, specifically a binomial lattice model incorporating the
Cox-Ross-Rubenstein methodology. For periods subsequent to the detachment of the
Public Warrants from the Units, the Public Warrant quoted market price was used
as the fair value as of each relevant date.
26
Table of Contents
Common Stock Subject to Possible Redemption
We account for our common stock subject to possible conversion in accordance
with the guidance in ASC Topic 480 "Distinguishing Liabilities from Equity."
Common stock subject to mandatory redemption is classified as a liability
instrument and measured at fair value. Conditionally redeemable common stock
(including common stock that features redemption rights that are either within
the control of the holder or subject to redemption upon the occurrence of
uncertain events not solely within our control) is classified as temporary
equity. At all other times, common stock is classified as stockholders' equity.
Our Class A common stock features certain redemption rights that are considered
to be outside of our control and subject to occurrence of uncertain future
events. Accordingly, Class A common stock subject to possible redemption is
presented at redemption value as temporary equity, outside of the stockholders'
deficit section of our condensed balance sheets.
Net(loss) income Per Common Share
Net income (loss) per common share is computed by dividing net income (loss) by
the weighted average number of common shares outstanding during the period. We
apply the two-class method in calculating income (loss) per common share.
Remeasurement associated with the redeemable shares of Class A common stock is
excluded from income (loss) per common share as the redemption value
approximates fair value.
Recent Accounting Standards
In August 2020, the FASB issued ASU 2020-06 to simplify accounting for certain
financial instruments ASU 2020-06 eliminates the current models that require
separation of beneficial conversion and cash conversion features from
convertible instruments and simplifies the derivative scope exception guidance
pertaining to equity classification of contracts in an entity's own equity. The
new standard also introduces additional disclosures for convertible debt and
freestanding instruments that are indexed to and settled in an entity's own
equity. ASU 2020-06 amends the diluted earnings per share guidance, including
the requirement to use the if-converted method for all convertible instruments.
ASU 2020-06 is effective January 1, 2024 and should be applied on a full or
modified retrospective basis, with early adoption permitted beginning on January
1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06
would have on its financial position, results of operations, or cash flows.
Management does not believe that any other recently issued, but not yet
effective, accounting standards, if currently adopted, would have a material
effect on our condensed financial statements.
© Edgar Online, source Glimpses